• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定和筛选适合初步筛选的“优势片段”。

Identification and selection of "privileged fragments" suitable for primary screening.

作者信息

Gianti Eleonora, Sartori Luca

机构信息

Computational Sciences Group, Department of Chemistry (Congenia s.r.l.), Genextra S.p.A., Milan MI 20100, Italy.

出版信息

J Chem Inf Model. 2008 Nov;48(11):2129-39. doi: 10.1021/ci800219h.

DOI:10.1021/ci800219h
PMID:18991373
Abstract

The use of small molecule libraries for fragment-based primary screening (FBS) is a well-known approach to identify protein binders in the low affinity range. However, the search, analysis, and selection of suitable screening fragments can be a lengthy process, because of the large number of compounds that must be analyzed for different levels of ring/substituents identification and submitted to selection/exclusion criteria based on their physicochemical properties. The purpose of the present work is to propose a strategy to identify substructures from databases of known drugs, which can be used as templates for the generation of libraries of "privileged fragments" that are able to provide high-quality hits. The entire process has been developed integrating Pipeline Pilot (Accelrys Inc., San Diego, CA; http://www.accelrys.com ) native components and user-defined molecular files containing ISIS-like substructure query features (Symyx, San Ramon, CA; http://www.symyx.com ). The method is effortless, easy to put in place, and fast enough to be iteratively applied to different sources of druglike compounds.

摘要

使用小分子文库进行基于片段的初筛(FBS)是一种在低亲和力范围内识别蛋白质结合物的知名方法。然而,由于必须针对不同水平的环/取代基识别分析大量化合物,并根据其物理化学性质提交至选择/排除标准,因此寻找、分析和选择合适的筛选片段可能是一个漫长的过程。本研究的目的是提出一种从已知药物数据库中识别子结构的策略,该策略可作为生成能够提供高质量命中物的“特权片段”文库的模板。整个过程是通过整合Pipeline Pilot(Accelrys公司,加利福尼亚州圣地亚哥;http://www.accelrys.com )原生组件和包含ISIS类子结构查询功能的用户定义分子文件(Symyx公司,加利福尼亚州圣拉蒙;http://www.symyx.com )来开发的。该方法简便易行,易于实施,且速度足够快,可迭代应用于不同来源的类药物化合物。

相似文献

1
Identification and selection of "privileged fragments" suitable for primary screening.鉴定和筛选适合初步筛选的“优势片段”。
J Chem Inf Model. 2008 Nov;48(11):2129-39. doi: 10.1021/ci800219h.
2
Efficient substructure searching of large chemical libraries: the ABCD chemical cartridge.高效的大型化学文库亚结构搜索:ABCD 化学盒。
J Chem Inf Model. 2011 Dec 27;51(12):3113-30. doi: 10.1021/ci200413e. Epub 2011 Nov 14.
3
Chemical substructures that enrich for biological activity.富集生物活性的化学亚结构。
Bioinformatics. 2008 Nov 1;24(21):2518-25. doi: 10.1093/bioinformatics/btn479. Epub 2008 Sep 10.
4
HAD: an automated database tool for analyzing screening hits in drug discovery.HAD:一种用于分析药物发现中筛选命中结果的自动化数据库工具。
J Chem Inf Comput Sci. 2003 Sep-Oct;43(5):1668-72. doi: 10.1021/ci034067s.
5
Targets looking for drugs: a multistep computational protocol for the development of structure-based pharmacophores and their applications for hit discovery.寻找药物的靶点:基于结构的药效团开发及其在先导化合物发现中的应用的多步计算方案
J Chem Inf Model. 2008 Nov;48(11):2166-79. doi: 10.1021/ci800105p.
6
BioCores: identification of a drug/natural product-based privileged structural motif for small-molecule lead discovery.生物核:基于药物/天然产物的小分子先导化合物发现的特权结构基序的鉴定。
Mol Divers. 2010 Feb;14(1):193-200. doi: 10.1007/s11030-009-9157-5. Epub 2009 May 26.
7
Evaluation of pKa estimation methods on 211 druglike compounds.评价 211 个类药性化合物的 pKa 估算方法。
J Chem Inf Model. 2010 Apr 26;50(4):565-71. doi: 10.1021/ci100019p.
8
Virtual screening for R-groups, including predicted pIC50 contributions, within large structural databases, using Topomer CoMFA.使用Topomer CoMFA在大型结构数据库中对R基团进行虚拟筛选,包括预测的pIC50贡献。
J Chem Inf Model. 2008 Nov;48(11):2180-95. doi: 10.1021/ci8001556.
9
Large scale meta-analysis of fragment-based screening campaigns: privileged fragments and complementary technologies.基于片段筛选研究的大规模荟萃分析:优势片段与互补技术
J Biomol Screen. 2015 Jun;20(5):588-96. doi: 10.1177/1087057114565080. Epub 2014 Dec 30.
10
Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening.用于药物筛选的市售化合物库的类药性和疏水性增加。
Curr Top Med Chem. 2012;12(14):1500-13. doi: 10.2174/156802612802652466.

引用本文的文献

1
"Molecular Anatomy": a new multi-dimensional hierarchical scaffold analysis tool.“分子解剖学”:一种新型的多维分层支架分析工具。
J Cheminform. 2021 Jul 23;13:54. doi: 10.1186/s13321-021-00526-y. eCollection 2021.
2
Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence.自动化和人工智能时代的血吸虫病药物发现。
Front Immunol. 2021 May 31;12:642383. doi: 10.3389/fimmu.2021.642383. eCollection 2021.
3
The Light and Dark Sides of Virtual Screening: What Is There to Know?虚拟筛选的光明面与黑暗面:有哪些需要了解的?
Int J Mol Sci. 2019 Mar 19;20(6):1375. doi: 10.3390/ijms20061375.
4
Computational analysis of EBNA1 "druggability" suggests novel insights for Epstein-Barr virus inhibitor design.EBNA1“可成药”性的计算分析为Epstein-Barr病毒抑制剂设计提供了新见解。
J Comput Aided Mol Des. 2016 Apr;30(4):285-303. doi: 10.1007/s10822-016-9899-y. Epub 2016 Apr 5.
5
Design of a fragment library that maximally represents available chemical space.设计一个最大限度地代表可用化学空间的片段库。
J Comput Aided Mol Des. 2011 Jul;25(7):611-20. doi: 10.1007/s10822-011-9461-x. Epub 2011 Jul 27.
6
Small molecules and stem cells. Potency and lineage commitment: the new quest for the fountain of youth.小分子与干细胞。潜能与谱系定向:对青春源泉的新探索。
J Med Chem. 2010 May 13;53(9):3439-53. doi: 10.1021/jm901361d.